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Abstract
cDNA fragments encoding mouse ferredoxin and ferredoxin reductase were simultaneously introduced into COS7 cells
by using an expression vector, pUC-SR a plasmid. When using the mitochondrial fraction prepared from the transfected
cells, cytochrome-c reductase activity was detected. This activity was highest when 7.5 mg of the ferredoxin expression
 .  .plasmid pSR a F and 2.5 mg of the ferredoxin reductase expression plasmid pSR a FR were transfected into COS7 cells.
In this system, NADPH could be replaced by NADH as a cofactor for the reduction of cytochrome c although the
cytochrome-c reductase was more dependent on NADPH than NADH at a low concentration. When CYP24 expression
plasmid was transfected into COS7 cells along with both pSR a F and pSR a FR, the transfected cells revealed a 3-fold
higher 25-hydroxyvitamin D -24-hydroxylase activity than COS7 cells transfected with CYP24 expression plasmid.3
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1. Introduction
Mitochondrial P450s generally function in the hy-
w xdroxylation of steroids, bile acids and vitamin D 1 .
Abbreviations: DEAE, diethylaminoethyl; DMEM, Dulbecco’s
modified Eagle medium; DTT, dithiothreitol; EDTA, ethylenedi-
amine tetraacetate; FCS, fetal calf serum; P450, cytochrome
P450; SDS, sodium dodecyl sulfate; SSC, sodium chloride-sodium
citrate solution.
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P450s are known to be present in microsomal and
mitochondrial membranes. Each membrane contains
different electron transport chain. The mitochondrial
enzyme system consists of P450, ferredoxin and
ferredoxin reductase. Ferredoxin is a 12–14 kDa iron
sulfur protein located in the mitochondrial matrix,
which acts as an electron shuttle between ferredoxin
reductase and P450s. Ferredoxin reductase is a 50
kDa flavoprotein located in the mitochondrial inner
membrane. Mitochondrial P450s receive electrons
from NADPH through these two intermediates as
follows. NADPH first interacts with the ferredoxin
reductase which passes electrons to ferredoxin. Then,
ferredoxin donates electrons to mitochondrial P450s.
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Subsequently, mitochondrial P450s provide electrons
w xto substrates to form hydroxylated products 2 .
Recently, cDNAs and genes corresponding to
ferredoxin and ferredoxin reductase were isolated
w xfrom mammals 3–19 . Obtained cDNAs were ex-
pressed in yeast, Escherichia coli and established
wmammalian cells to investigate their functions 20–
x28 . On the other hand, there are very few reports in
which the double transfection of expression plasmids
for ferredoxin and ferredoxin reductase was per-
formed. Even if the double transfection of these
expression plasmids is carried out in COS cells, the
optical condition for the maximum activity is not
w xinvestigated 23,28 . Thus, we tried to examine the
optical condition when the double transfection of
expression plasmids for ferredoxin and ferredoxin
reductase into COS7 cells was undergone. In addi-
tion, we also examined whether or not this system
can be used for the measurement of CYP24 as a
representative mitochondrial P450.
2. Materials and methods
2.1. Expression plasmids
w xFull-length mouse ferredoxin 18 and ferredoxin
w xreductase 19 cloned in our laboratory were used to
construct expression plasmids. The plasmid, pSR a F,
was constructed by the ligation of the following two
 .DNA fragments: a a 0.6-kb SmaI-SspI fragment of
 .F41-1; and b a 5.0-kb Pst I-digested pUC-SR a
w xplasmid 29 whose sites were blunt-ended. The plas-
mid, pSR a FR, was constructed by the ligation of the
 .following two DNA fragments: a a 1.6-kb NheI-
SacI fragment of FR7-1, whose sites were blunt-
 .ended; and b a 5.0-kb Pst I-digested pUC-SR a
plasmid whose sites were blunt-ended.
2.2. Cell culture and the transfection of expression
plasmids
COS7 cells were grown in DMEM containing 10%
heat-inactivated FCS. They were seeded at a density
of 1.2=106 cells in 100-mm tissue culture dishes
one day before the transfection. The expression plas-
mid pSR a F, pSR a FR or pSR a-Cyp24 was trans-
fected into COS7 cells by the DEAE-dextran method
w x  .30 . Briefly, the expression plasmids 10 or 15 mg
dissolved in 2 ml of RSC DMEM containing 2%
.FCS and 100 mM chloroquine plus 2 ml of RSC
containing 0.08% DEAE-dextran were added to the
plate after the culture medium was removed. Four
hours later, the transfection mixture was removed and
the cells were treated with 10% dimethylsulfoxide in
phosphate-buffered saline for 2 min. The cells were
then returned to DMEM containing 10% FCS and
were further cultured for 48 h.
2.3. Preparation of total RNA
Total RNA was prepared by the acid-guanidinium
w xphenol-chloroform method 31 .
2.4. Preparation of mitochondrial fraction
We prepared the mitochondrial fraction from COS7
cells by the modified method described by Inaba et
w xal. 32 . Briefly, the cells were homogenized in 5
 . volumes wrv of buffer A 0.25 M sucrose, 15 mM
 . .Tris pH 7.4 , 1 mM EDTA and 1 mM DTT . The
homogenate was centrifuged at 600=g for 15 min
four times to remove nuclei and cell debris. The
supernatant was further centrifuged at 9000=g for
15 min. The pellet was washed twice and finally
resuspended in distilled water. The concentration of
mitochondrial protein was determined by the method
w xof Lowry et al. 33 . The mitochondrial fraction
obtained was stored at y808C until use.
2.5. Northern blot analysis
w x  .For Northern blot analysis 30 , total RNA 2 mg
was electrophoresed in a 0.8% agarose gel containing
6% formaldehyde and transferred to a nylon mem-
brane. The membrane was prehybridized for more
than 12 h in 50 mM sodium phosphate buffer pH
.6.5 containing 50% formamide, 0.5=SSC, and 0.28
mgrml denatured salmon sperm DNA at 428C and
hybridized overnight in the same buffer with the
32P-labeled hybridization probe at 428C. The mem-
brane was washed twice at a 30-min interval with
0.5=SSC containing 0.2% SDS at 508C.
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2.6. Western blot analysis
Western blot analysis of ferredoxin and ferredoxin
reductase expressed in the mitochondrial fraction from
COS7 cells was carried out using polyclonal rabbit
antibodies to bovine ferredoxin and ferredoxin reduc-
w xtase 34 and horseradish peroxidase-conjugated Pro-
 .tein ArG Pierce, Rockford, IL . Immunodetection
was performed with luminescence reagent set Wako,
.Osaka, Japan under the manufacturer’s recom-
mended conditions.
2.7. Measurement of cytochrome-c reductase acti˝ity
Cytochrome c reduction was assayed in 350 mM
 .sodium phosphate buffer pH 7.6 containing 1 mM
KCN, 50 mM cytochrome c and varying concentra-
tions of the mitochondrial proteins. The reaction was
generally initiated by the addition of 42 mM NADPH
w x35–37 . If necessary, NADPH was replaced by
NADH, NADPq or NADq. The absorbance change
at 550 nm was monitored, and the activity was
determined using De s21 mMy1 cmy1. The cy-550
tochrome-c reductase activity in COS7 cells trans-
fected with 10 mg of pUC-SR a plasmid was 27.0
nmolrmgrmin.
3. Results
3.1. Simultaneous expression of ferredoxin and ferre-
doxin reductase in COS7 cells
It is known that mitochondrial P450s require elec-
trons for the oxidation of various substrates. Ferre-
doxin and ferredoxin reductase are proteins in a short
electron transport chain that supply electrons to mito-
chondrial P450s. However, there are very few reports
that both ferredoxin and ferredoxin reductase can be
simultaneously expressed in mammalian cells with
the method of DNA transfection although there were
several reports that the expression plasmids for mito-
chondrial P450 and ferredoxin were co-transfected
w xinto the mammalian cells 38–40 . Thus, we tried to
simultaneously introduce the expression plasmids for
 .ferredoxin pSR a F and ferredoxin reductase
 .pSR a FR into COS7 cells. The activity of cy-
Table 1
Cytochrome-c reductase activity in COS7 cells transfected with
different amounts of ferredoxin and ferredoxin reductase expres-
sion plasmids
 . Cytochrome-cAmount of plasmid mg
reductase activitypSR a F pSR a FR
 .nmolrmg proteinrmin
10.0 0 10.8
9.0 1.0 29.8
7.5 2.5 55.5
5.0 5.0 46.0
2.5 7.5 36.7
1.0 9.0 14.8
0 10.0 2.7
Each value is corrected for the activity in the mitochondrial
fraction from COS7 cells transfected with 10 mg of pUC-SR a
plasmid.
The data are shown as the means of duplicate experiments.
tochrome-c reductase was detected in the mitochon-
drial fraction prepared from COS7 cells when the
different amounts of pSR a F and pSR a FR were
transfected into COS7 cells. The level of activity was
highest when 7.5 mg of pSR a F and 2.5 mg of
 .pSR a FR were co-transfected into the cells Table 1 .
To examine the expression of mRNAs for ferredoxin
and ferredoxin reductase, we performed Northern blot
analysis using mouse ferredoxin or ferredoxin reduc-
w xtase as a probe 18,19 . As shown in Fig. 1, mRNAs
corresponding to ferredoxin and ferredoxin reductase
could be detected in COS7 cells transfected with
 .pSR a F and pSR a FR lane 3 . However, The low
endogenous levels of ferredoxin and ferredoxin re-
ductases mRNAs present in COS7 cells could not be
seen in the total RNAs prepared from COS7 cells
 .lane 1 and COS7 cells transfected with pUC-SR a
 .lane 2 as described by Harikrishna et al. who used
w xCOS1 cells 28 . This reason is probably due to the
 .application of small amounts 2 mg of total RNA in
the gel. The existence of the translational product of
the mouse ferredoxin and ferredoxin reductase cD-
NAs in mitochondria from COS7 cells was measured
by Western blot analysis. The results of Western blot
analysis using antibodies to bovine ferredoxin or
ferredoxin reductase are shown in Fig. 2. Proteins in
mitochondria from COS7 cells transfected with
 .pSR a F and pSR a F lane 3; upper , but not from
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Fig. 1. Northern blot analysis of mouse ferredoxin and ferredoxin
reductase mRNAs in COS7 cells transfected with expression
 .plasmids. Total RNA 2 mg isolated from COS7 cells trans-
fected with expression plasmids was applied. Lane 1: COS7 cells,
 .lane 2: COS7 cells transfected with pUC-SR a 10 mg , lane 3:
 . COS7 cells transfected with pSR a F 7.5 mg and pSR a FR 2.5
.mg .
 .COS7 lane 1; upper and COS7 cells transfected
 .with pUC-SR a lane 2; upper , immunochemically
reacted with anti-bovine ferredoxin antibodies. On
the other hand, COS7 cells transfected with pSR a F
 .and pSR a F lane 3; lower expressed proteins in
Fig. 2. Western blot analysis of mouse ferredoxin and ferredoxin
reductase proteins in COS7 cells transfected with expression
plasmids. Eight micrograms of proteins in mitochondria from
COS7 cells transfected with expression plasmids was applied to a
well, electrophoretically separated on a 12% SDS gel and de-
tected by immunoblotting with rabbit anti-bovine ferredoxin up-
.  .per or anti-bovine ferredoxin reductase antibody lower . Lane 1:
COS7 cells, lane 2: COS7 cells transfected with pUC-SR a 10
.  .mg , lane 3: COS7 cells transfected with pSR a F 7.5 mg and
 .pSR a FR 2.5 mg . The X-ray films were exposed for 2 h at
y808C.
Fig. 3. Effect of mitochondrial fraction from COS7 cells trans-
 .  .fected with pSR a F 7.5 mg and pSR a FR 2.5 mg on the
activity of cytochrome-c reductase. Each value is corrected for
the activity in the mitochondrial fraction from COS7 cells trans-
 .fected with pUC-SR a 10 mg alone. The data are shown as the
means of duplicate experiments.
mitochondria reactive with anti-bovine ferredoxin re-
ductase antibodies. The size of proteins reactive with
anti-bovine ferredoxin reductase antibodies in dou-
ble-transfected COS7 cells was a little different from
 .that in COS7 cells lane 1; lower or COS7 cells
 .transfected with pUC-SR a lane 2; lower . Thus, we
transfected 7.5 mg of pSR a F and 2.5 mg of pSR a FR
into COS7 cells in the following experiments.
The relationship between mitochondrial protein
concentrations and the reduction of cytochrome c
catalyzed by the mitochondrial fraction from COS7
cells expressing both ferredoxin and ferredoxin re-
ductase are shown in Fig. 3. The reduction of cy-
Fig. 4. Time course for cytochrome-c reductase activity in COS7
 .  .cells transfected with pSR a F 7.5 mg and pSR a FR 2.5 mg .
Each value is corrected for the activity in the mitochondrial
 .fraction from COS7 cells transfected with pUC-SR a 10 mg
alone. The data are shown as the means of duplicate experiments.
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tochrome c gradually increased with up to 12.5
mgrml of the mitochondrial protein. On the other
hand, the reduction reached a plateau when more than
25.0 mgrml of mitochondrial protein was added to
the reaction mixture.
The relationship between incubation times and the
amounts of reduced cytochrome c is described in Fig.
4. The amounts of reduced cytochrome c increased
linearly with the incubation time up to 5 min. From
these results, the mitochondrial fraction was added to
a standard incubation mixture at a concentration of
12.5 mgrml, and subsequently incubated for 5 min at
258C in the following experiments.
3.2. Dependence of NADH or NADPH on cytochrome
c reduction
In general, ferredoxin reductase preferentially re-
w xquires NADPH for the electron transfer 41 . The
activity of cytochrome-c reductase in the mitochon-
drial fraction prepared from the transfected COS7
cells was almost the same when NADPH was re-
placed by NADH as a source of reducing equivalents
 . q q4.2 mM . On the other hand, NADP or NAD
could not act as electron donors for cytochrome c
reduction mediated by ferredoxin reductase data not
.shown . However, the addition of low amounts of
 .NADPH up to 2 mM resulted in 2–3 times higher
cytochrome-c reductase activity than for NADH Fig.
.5 .
Fig. 5. Dependence of cytochrome-c reductase activity on
NADPH and NADH. Each value is corrected for the activity in
the mitochondrial fraction from COS7 cells transfected with
 .pUC-SR a 10 mg alone. The data are shown as the means of
duplicate experiments.
3.3. 25-Hydroxy˝itamin D -24-hydroxylase acti˝ity in3
COS7 cells transfected with the expression plasmids
for ferredoxin, ferredoxin reductase and Cyp24
We investigated whether or not COS7 cells trans-
fected with the mouse CYP24 expression plasmid
w x42 in addition to pSR a F and pSR a FR possessed
higher activity of 25-hydroxyvitamin D -24-hydrox-3
ylase than those transfected with the mouse CYP24
expression plasmid alone. We examined whether or
not the mitochondrial fraction from COS7 cells trans-
fected with pSR a F, pSR a FR and the mouse CYP24
expression plasmid catalyzes 24-hydroxylation of
25-hydroxyvitamin D . As expected, the triple trans-3
fection of pSR a F, pSR a FR and the mouse CYP24
expression plasmid into COS7 cells revealed a higher
activity of 25-hydroxyvitamin D -24-hydroxylase3
 .44.5"1.6 pmolrmg proteinr30 min than the sin-
gle transfection of the mouse CYP24 expression plas-
 .mid 16.2"1.2 pmolrmg proteinr30 min or the
double transfection of pSR a F and pSR a FR 6.3"
.  .1.4 pmolrmg proteinr30 min data not shown .
4. Discussion
Mitochondrial P450s are known to receive elec-
trons from NADPH through two intermediates.
NADPH first interacts with ferredoxin reductase
which passes electrons to the small iron-sulfur pro-
tein, ferredoxin. Subsequently, ferredoxin donates
electrons to mitochondrial P450s. It has been demon-
strated that COS cells contain both of these electron
w xtransport proteins 28,38 . Thus, transfection of the
expression plasmid for mitochondrial P450 into the
cells results in detectable P450 activity. However, the
endogenous ferredoxin and ferredoxin reductase in
COS cells are possibly insufficient for the maximal
P450 activity when the expression plasmid for the
mitochondrial P450 alone is introduced into COS
cells. Thus, we tried to explore the best condition for
the electron transfer system in COS7 cells using the
expression plasmids for ferredoxin and ferredoxin
reductase. In this study, a cytochrome-c reductase
assay was widely used to examine whether or not
ferredoxin and ferredoxin reductase functioned as
electron transfer proteins in COS7 cells. Ferredoxin
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reductase cannot interact directly with cytochrome c.
Its interaction requires the mediation of ferredoxin
w x41,43 . When we transfected 7.5 mg of pSR a F and
2.5 mg of pSR a FR into COS7 cells, the highest
activity of cytochrome-c reductase appeared.
Hanukoglu and Hanukoglu reported that the molar
ratio of ferredoxin:ferredoxin reductase:P450 in
bovine adrenal to be 3:1:8 and in corpus luteum 2.5:
w x1:3 44 . Although we could not investigate the
amounts of the expressed proteins for ferredoxin and
ferredoxin reductase, it is suspected that the molecule
of the ferredoxin was more than that of the ferredoxin
reductase in COS7 cells transfected with pSR a F and
pSR a FR. However, we did not know the accurate
ratio in the present study since we could not obtain
the purified proteins.
NADH as well as NADPH is a source of reducing
 .equivalents. Even if NADPH 4.2 mM was replaced
 .by NADH 4.2 mM , the mitochondrial fraction pre-
pared from COS7 cells transfected with pSR a F and
pSR a FR showed almost the same activity of cy-
tochrome-c reductase. However, the addition of
NADPH predominantly showed cytochrome-c reduc-
tase activity at low concentrations of electron donors
 .0.5–2.1 mM , suggesting that the expressed proteins
in COS7 cells preferentially used NADPH.
Using the above expression system, we tried to
transfect the expression plasmid for CYP24 in addi-
tion to pSR a F and pSR a FR into COS7 cells. The
triple transfection resulted in higher activity of 25-hy-
droxyvitamin D -24-hydroxylase than the single3
transfection of pSR a-Cyp24. Nearly the same results
w x w xwere obtained using CYP11A1 28 and CYP27 45 .
However, they did not examine the best conditions
for cytochrome-c reductase activity. On the contrary,
We established the best conditions ferredoxin and
ferredoxin reductase mediated cytochrome-c reduc-
tase activity.
Thus, it is possible that the simultaneous expres-
sion system in COS7 cells is also able to be used for
the measurement of other mitochondrial cytochrome
P450 activities.
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